
ABOUT ISR REPORTS
Industry Standard Research – ISR Reports – is a full-service market research company operating exclusively in the pharmaceutical and pharmaceutical services industry. ISR’s syndicated and custom market research capabilities coupled with unparalleled industry expertise and experience, enables our customers to make smarter, more informed business decisions.
ISR’s syndicated reports are produced using direct feedback from decision-makers (primary market research) which enables us to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to our customers.
While our syndicated reports cover a wide-range of topics within the industry, sometimes clients have specific questions that need answering or they are searching for a certain target. ISR designs dozens of proprietary custom market research projects for clients every year. These studies are often used to assess new products and services, gauge customer satisfaction, measure brand strength, or test marketing messages.
ISR knows the industry. We have presented at bid defenses, owned P&Ls, written proposals to RFPs, designed and implemented marketing strategies, and negotiated strategic partnerships. These experiences translate to our work products. ISR operates exclusively in the pharmaceutical and pharmaceutical services industry, our knowledge of the space is current and detailed.
Give us a call or send us an email, we are always open to a conversation. If we can help we will, and if not, we will tell you.
You can also download our brochure here.
CONTACT INFORMATION
ISR Reports
5565 Centerview Drive
Raleigh, NC 27606
UNITED STATES
Phone: 919-301-0106
INFOGRAPHICS
- Top 5 improvements Needed In Today’s EDC Software Systems
- How To Improve eCOA/ePRO Software Systems
- Technology In Clinical Trials: Differences By Company Size
- Why Phase II/III Service Providers Lose Bids
- Patient Recruitment Challenges In Rare Disease Studies
- Central IRB Outsourcing Practices By Company Size
- Most Important Selection Criteria For Central IRB Services
- 3 Year Rolling Average – Phase I Service Provider Customer Loyalty
- Most Important Capabilities For Pharmacovigilance Services
- Preferred Provider Use Among Bioanalytical Lab Outsourcers
- Improving Clinical Logistics Outsourcing Relationships
- Top 5 Selection Attributes Gaining Importance For Outsourced Bioanalytical Lab Services
- Clinical Materials Distribution by Location
- 2018-2023 Edition Of The CRO Market Size Projections
- Most Important Attributes For EDC Provider Selection: Development vs. Post-Marketing
- Top 5 Selection Attributes For Outsourced eTMF Services
- The Impact Of mHealth Technologies On Clinical Trial Spending
- Preferred Provider Use For IRT Services
WEBINARS
FEATURED ARTICLES
- Warming Up To Hybrid Trials
- Rare Disease Studies: A Comfortable Patient Is A Retained Patient
- Provider Selection In Small And Emerging Pharma Companies
- Can CROs Rise To The Patient Access & Recruitment Challenge?
- Insights Into The Competitive Clinical Manufacturing Market
- Fast Track To Flexible Clinical Trials
- Trends In Clinical Development
- Industry Trends In Clinical Development Technology
- 6 Reasons You Don’t Use Pharmaceutical Market Research
- Insights in Pharmaceutical Manufacturing, Clinical Research and Technology
- Can Integrated Service Providers Help Simplify Complex Clinical Trial Logistics?
- The Quest To Improve Efficiency In Site Contract And Budget Negotiations
- CRO Selection Taken Seriously
- IRB Performance And Best Practices In Site Start-up: Review Of Two Recent Market Research Reports
- Services Marketing: You Can't Build A Strong Marketing Strategy On A Weak Foundation (Video Intro)
- How Services Marketers Can Own Their Performance (Video Intro)
- How Services Marketers Can Own Their Performance Measures
- Services Marketing: You Can’t Build A Strong Marketing Strategy On A Weak Foundation
- Decision-making Responsibilities When Outsourcing Late-Phase Studies
- How Will mHealth Benefit Clinical Trials?
- Influence Of Size In CRO Selection
- Don’t Let Insufficient Data Undermine Your CMO & CRO Selection Processes